Press Releases
February 27, 2008
Paolo Marcucci Has Joined PPTA's Global Board of Directors
ANNAPOLIS, MD—February 25, 2008—Paolo Marcucci, President and CEO of Kedrion, a company specializing in the development, production and distribution of plasma-derived products, has joined the Global Board of Directors of the Plasma Protein Therapeutics Association (PPTA).
December 12, 2007
Alabamans with Rare Diseases Declare Victory for Patient Care
ANNAPOLIS, MD--December 12, 2007--Patients enrolled in Alabama Medicaid, who rely on complex blood clotting factor therapies to control bleeding disorders such as hemophilia, achieved a recent victory that further secured their access to life-saving plasma-derived and recombinant analog therapies.
November 21, 2007
PPTA Honors Outgoing Chairmen
In special ceremonies held recently in conjunction with PPTA Source’s Business Forum in Anaheim, California and PPTA’s Global Board of Directors meeting in Washington, D.C., the Association honored three exemplary individuals who have served as guiding forces in the plasma protein therapeutics industry.
October 26, 2007
LAWRENCE P. GUIHEEN ELECTED PPTA GLOBAL BOARD CHAIRMAN
WASHINGTON, D.C.—October 26, 2007—Lawrence P. Guiheen of Baxter International Inc. today was appointed chairman of the Plasma Protein Therapeutics Association (PPTA) global board of directors, starting his new role on January 1, 2008.
August 23, 2007
PPTA Names New Communications Manager
ANNAPOLIS, MD—August 7, 2007—The Plasma Protein Therapeutics Association (PPTA) has named Kym H. Kilbourne as its new communications manager.
March 24, 2005
Dr. med. Wolfhart Kreuz Wins Hilfenhaus Award 2005
Award presentation at the International Plasma Protein Congress 2005 in Berlin, Germany on March 8, 2005.
July 20, 2004
Industry Organization Calls Upon State Legislatures to Enact Medicaid Prior Authorization Exemptions for Life-Saving Plasma Therapies
Results of Texas Study Show that Prior Authorization is not appropriate for Anti-hemophiliac Blood Clotting Factor Therapies
July 02, 2004
PPTA Updates Voluntary Industry Standards
PPTA Updates Voluntary Industry Standards. Changes include revision of previous requirements, addition of new standardsa and removal of obsolete standards (020677)
July 30, 2003
Grifols Receives QSEAL Certification
The Plasma Protein Therapeutics Association (PPTA) announced that Instituto Grifols is the sixth company to be certified through its international Quality Standards of Excellence, Assurance, and Leadership (QSEAL) Program. PPTA President Jan M. Bult explained that “Grifols has successfully met the criteria of the voluntary program that was designed to demonstrate the leadership of this industry through the development of initiatives that enhance the continued safety and quality of lifesaving plasma therapeutics.”
October 07, 2002
Industry Confirms Plasma Therapies Safe from West Nile Virus
Plasma-derived products do not represent a risk for the transmission of the West Nile Virus.
November 07, 2001
QSEAL Recipients Recognized on Capitol Hill
On November 7, Congresswoman Hilda L. Solis of California hosted a presentation ceremony in her Capitol Hill office for members of the Plasma Protein Therapeutics Association (PPTA) who are the first to receive certification through the Association's QSEAL (Quality Standards of Excellence Assurance and Leadership) Program.